Patent · US Active

Thiazolyl-dihydro-quinazoline

US7691868B2 · kind B2 · utility

1Cited by

1References

9Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Trixi Brandl · Warthausen, DE
Udo Maier · Senden, DE
Matthias Hoffmann · Mittelbiberach, DE
Stefan Scheuerer · Warthausen, DE
Anne T. Joergensen · Copenhagen, DK
Alexander Pautsch · Ulm, DE
Steffen Breitfelder · Aßmannshardt, DE
Matthias Grauert · Ingelheim am Rhein, DE
Christoph Hoenke · Ingelheim am Rhein, DE
Klaus Erb · Mittelbiberach, DE
Michael Pieper · Biberach, DE
Ingo Pragst · Marburg, DE

Key dates

Filing date	Mar 23, 2007
Grant date	Apr 6, 2010
Priority date	—
Expiry date	Mar 23, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are thiazolyl-dihydro-quinazolines of general formula (I)wherein the groups R1 to R4 have the meanings given in the claims and specification, the isomers thereof, and processes for preparing these compounds and their use as pharmaceutical compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.